ASTRO publishes evidence-based guideline for thoracic radiotherapy

The American Society for Radiation Oncology (ASTRO) has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.

Many patients whose lung cancer has spread receive radiation therapy to treat symptoms related to cancer, such as cough, shortness of breath, bronchial obstruction and chest pain. However, the exact treatment approach can vary from doctor to doctor. This variation caused the Guidelines Subcommittee of ASTRO's Clinical Affairs and Quality Committee (CAQC) to identify the use of palliative thoracic (or chest) radiation therapy as a high-priority topic needing an evidence-based guideline.

This panel was co-chaired by George Rodrigues, MD, MSc, a radiation oncologist and clinician scientist at London Health Sciences Centre in London, Ontario, Canada, and Benjamin Movsas, MD, chairman of at Henry Ford Health System in Detroit.

"Radiation therapy can be extremely helpful to alleviate symptoms caused by lung cancer, such as shortness of breath and chest pain," Dr. Rodrigues said.

ASTRO's Board of Directors then put together a multidisciplinary task force that was charged with reviewing and synthesizing the current evidence to develop a guideline to help radiation oncologists determine the appropriate use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy for palliative intent for lung cancer patients.

The task force's main findings are:

1. Various regimens of thoracic therapy are very effective for palliation of symptoms, with moderately higher dose regimens associated with a modest improvement in survival for selected patients primarily with good performance status.

2. There is no evidence to recommend the use of endobronchial brachytherapy in the routine initial palliative management of lung cancer. Endobronchial brachytherapy is a type of internal radiation therapy used to treat lung cancer in or near the patient's airway.

3. There is no added benefit to patients to use chemotherapy at the same time as radiation therapy in the relief of thoracic symptoms for lung cancer patients. However, optimally integrating sequential chemotherapy and is important in the management of symptoms.

Dr. Movsas said, "It is our hope that this evidence-based guideline will help doctors determine the optimal palliative radiation treatments for , thereby yielding improved quality of life."

More information: For a copy of the guideline, visit www.astro.org/research

Provided by American Society for Radiation Oncology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Radiation therapy combo cures prostate cancer long-term

Jan 04, 2007

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study ...

Recommended for you

Survival differences seen for advanced-stage laryngeal cancer

15 hours ago

The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a total laryngectomy (removal ...

Gene test aids cancer profile

Nov 27, 2014

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.